← All claims

Longevity & Aging · Metabolic & Cardiometabolic

fasting-mimicking diet causes pancreatic beta-cell regeneration and diabetes reversal

In plain terms: Can the fasting-mimicking diet regrow insulin-producing cells and reverse diabetes in people?

Leans against Longevity & Aging 🐭 Non-human evidence🔬 Includes disconfirming

Part of: • Fasting & Time-Restricted Eating

RefutedContestedStrong support
consensus score -0.30
⚖️ Thin evidence — read the needle loosely. The score shows which way the studies lean, but there are too few independent, high-quality ones to place it firmly. Expect this to move as better evidence arrives.

Compelling in mice and human islet cell-culture, but there is NO in-vivo human evidence of FMD-driven beta-cell regeneration or diabetes reversal — the human claim is unproven.

📅 Last reviewed: 2026-07-14 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Animal studies (Animal)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

2 support 1 contradict 0 tested null 0 mixed · 3 sources, 3 independent groups

What the evidence shows

The regeneration finding is compelling in mice and in human islet cell culture, where fasting-mimicking cycles drove Ngn3-mediated beta-cell regeneration. There is no in-vivo human evidence of it, and the human trials that do achieve diabetes remission did so with total diet replacement and by clearing organ fat, which is a different mechanism from neogenesis.

The evidence (6)

SourceGradeStanceQualityFinding
Cheng CW, Villani V, Buono R, Wei M, Kumar S, Yilmaz OH, Cohen P, Sneddon JB, Perin L, Longo VD
2017 · Cell
animal supports moderate MOUSE (T1D/T2D models) plus human islet in-vitro: FMD drove Ngn3-mediated beta-cell regeneration and restored insulin; human data are cell-culture only, no in-vivo human outcome. Longo-lab.
Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Stefanetti R, Trenell M, Welsh P, Kean S, Ford I, McConnachie A, Sattar N, Taylor R
2018 · Lancet
RCT contradicts high INDIRECT (intervention: DiRECT administered total diet replacement, never an FMD). Open-label cluster-randomised trial, 306 adults with T2D in UK primary care: 24% lost >=15 kg and remission tracked weight loss, with restored beta-cell FUNCTION via fat clearance rather than neogenesis. Bears on the claim's outcome limb -- human remission is achievable without FMD and by a different mechanism -- but it is not a test of FMD-driven beta-cell regeneration.
Spears E, Serafimidis I, Powers AC, Gavalas A
2021 · Frontiers in endocrinology
observational mixed low Review of beta-cell regeneration/neogenesis pathways (proliferation vs progenitor differentiation vs transdifferentiation); explicitly notes findings are largely from MOUSE models and that consensus is lacking on relevance to HUMANS.
Castelblanco E, Shyr ZA, Ramirez-Sotero I, Yan Z, Chen SX, Diwan A, Remedi MS
2025 · Diabetologia
animal supports moderate MOUSE: alternate-day intermittent fasting in KATP-gain-of-function (neonatal diabetes model) mice restored beta-cell autophagic flux and re-established beta-cell identity, lowering blood glucose. No human data.
Napoleão A, Fernandes L, Miranda C, Marum AP
2021 · Nutrients
observational mixed low Review comparing calorie restriction/ketosis-inducing diets including fasting-mimicking diet (FMD) on insulin resistance in HUMANS; concludes benefits on insulin sensitivity/metabolic parameters but reports 'insufficient evidence' for long
Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Welsh P, Kean S, Ford I, McConnachie A, Messow CM, Sattar N, Taylor R
2019 · Lancet Diabetes Endocrinol
RCT contradicts high DUPLICATE POPULATION: the 2-year report of the SAME DiRECT cohort as s29221645, so the cohort must not vote twice (precedent: CLEAR Harmony extension, 2026-08-19). Content unchanged -- durable remission is weight-loss-dependent and reverses on weight regain, again without any FMD exposure.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.